Replies to post #86994 on Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

Share buyback would be nice; but it wont happen as every dollar will be plowed back into the MANF development programs (as you already know).

As you said too: we are reaching a critical tipping point (as I always thought Q3/Q4 will be a possible a very defining moment in the company's history and future success).

Finally, I think their is something both eerie but yet powerful about all the silence lately (the Insider and constituents have loaded the boat); and they will certainly more than likely expect a nice return for their investment. Moreover, I always believe if you have the capability to connect the dots (the runway has been set for takeoff).

[Riskreturn168]

You mean when we start getting Licensing/Partnership deals on MANF indications and we have more money than Apple. Yes, at some point we'll have the money to do a share buy back. But do you think we'll be in that position within the next year? Whereas, I'm thinking Gerald wants to up list...yesterday! So, by margining within days of up listing, and maybe even before a LymPro Sales Partner is announced, one could really score big time using margin money. Risk is involved, no doubt, but everyone who has invested in this stock in the first place...seems comfortable with risk.